Quick Answer
Moleculin Biotech, Inc. reported Shares Outstanding of 3.20 million shares for fiscal year 2025.
Moleculin Biotech, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 3.20M | +2267.1% |
| 2024 | 135,155 | -93.9% |
| 2023 | 2.23M | +16.7% |
| 2022 | 1.91M | -93.3% |
| 2021 | 28.58M | +147.7% |
| 2020 | 11.54M | +51.4% |
| 2019 | 7.62M | -73.3% |
| 2018 | 28.53M | +32.9% |
| 2017 | 21.47M | +76.5% |
| 2016 | 12.16M | +82.6% |
| 2015 | 6.66M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 49.50M | +1548.9% | +63.9% |
| June 30, 2025 | 30.21M | +1079.6% | +113.8% |
| March 31, 2025 | 14.13M | +511.2% | +318.1% |
| December 31, 2024 | 3.38M | +51.7% | +12.6% |
| September 30, 2024 | 3.00M | -89.9% | +17.2% |
| June 30, 2024 | 2.56M | -91.4% | +10.8% |
| March 31, 2024 | 2.31M | -92.2% | +3.8% |
| December 31, 2023 | 2.23M | -92.2% | -92.5% |
- Moleculin Biotech, Inc. showed an increase of +2267.1% in Shares Outstanding compared to the prior fiscal year.
- Over the 2015–2025 period, Moleculin Biotech, Inc.’s shares outstanding has declined by 52.0% (from 6.66 million shares to 3.20 million shares).
- The most recent figure is from Moleculin Biotech, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: